Soft and Hard Tissue Changes Around the New Lance® Implants Using Traditional and Switch Platform Abutments
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Rambam Health Care Campus.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Rambam Health Care Campus
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01234584
First received: November 3, 2010
Last updated: December 7, 2010
Last verified: September 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this present study is to compare alveolar bone changes and markers of gingival health around the new Lanes® dental implant which were rehabilitate using the new switch platform abutment ( SPR ) and the traditional ( CPK ) abutment.
| Condition | Intervention |
|---|---|
|
Group A- 23 Implant Using Switch Platform -SPK Abutment. Group B- 22 Implant Using the Traditional -CPK Abutment. |
Procedure: spk Procedure: CPK Abutments |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
Further study details as provided by Rambam Health Care Campus:
Primary Outcome Measures:
- Soft tissue evaluation: [ Time Frame: 12 month ] [ Designated as safety issue: Yes ]Three month following abutment connection (approximately 2 months following cementation of the final crowns) baseline measurement will be taken. This will include probing pockets depth (PPD) and bleeding on probing (BOP) dichotomized in to 0 and 1 This measurement will be repeated at 12 month post surgery.
- Radiographic evaluation: [ Time Frame: 12 month post surgery ] [ Designated as safety issue: Yes ]
Bite wing radiographs will be used to assess changes in radiographic bone height.
Baseline radiographs will be taking immediately following abutment connection and final radiographic evaluation will be taken 12 months post surgery.
| Estimated Enrollment: | 45 |
| Study Start Date: | September 2010 |
| Estimated Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Group A
23 implants using SPK Abutments
|
Procedure: spk
implants using SPK Abutments
|
|
Active Comparator: Group B
implants using CPK Abutments
|
Procedure: CPK Abutments
implants using CPK Abutments
|
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Adult patient aged 18 - 80 yrs.
- Implants treatment planned for single crown rehabilitation.
- Submerged implant placement.
- Patients willing to participate in a twelve month study.
- Up to 2 implants per patient will be allowed.
Exclusion Criteria:
- Active periodontal disease.
- Systemic condition and medication that may affect soft and hard tissue healing.
- Pregnancy or intention to become pregnant in the next twelve months.
- Parafunctional occlusal scheme and habits.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01234584
Locations
| Israel | |
| Department of Maxillofacial Rehabillitaion School of Graduate Dentistry Rambam Health care campus | Recruiting |
| Haifa, Israel | |
| Contact: Zvi Gutmacher, DMD +97252-5777636 dr_zviu3@netvision.net.il | |
| Sub-Investigator: Eli Machtei, DMD | |
| Sub-Investigator: Israel Blumenfeld, DMD | |
Sponsors and Collaborators
Rambam Health Care Campus
More Information
No publications provided
| Responsible Party: | Dr. zvi Gutmacher, Department of Maxillofacial Rehabilitation School of Gradute Dentistry Rambam Health care campus Haifa, Israel |
| ClinicalTrials.gov Identifier: | NCT01234584 History of Changes |
| Other Study ID Numbers: | CTIL0227-10-RMB |
| Study First Received: | November 3, 2010 |
| Last Updated: | December 7, 2010 |
| Health Authority: | Israel: IRB |
ClinicalTrials.gov processed this record on May 19, 2013